Shares of Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) rose 8.1% on Monday . The company traded as high as $26.56 and last traded at $26.48. Approximately 731,559 shares changed hands during mid-day trading, a decline of 8% from the average daily volume of 795,331 shares. The stock had previously closed at $24.49.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on SDGR shares. Piper Sandler dropped their price objective on Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. KeyCorp lifted their price objective on shares of Schrödinger from $30.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $33.00.
Read Our Latest Stock Analysis on SDGR
Schrödinger Stock Up 2.1 %
The stock has a market capitalization of $1.88 billion, a price-to-earnings ratio of -11.00 and a beta of 1.77. The stock has a 50 day moving average price of $22.01 and a 200 day moving average price of $20.98.
Schrödinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20). The company had revenue of $88.32 million during the quarter, compared to the consensus estimate of $83.20 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. Sell-side analysts forecast that Schrödinger, Inc. will post -2.37 earnings per share for the current fiscal year.
Insider Activity at Schrödinger
In other Schrödinger news, CFO Geoffrey Craig Porges sold 5,491 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the transaction, the chief financial officer now directly owns 27,544 shares of the company's stock, valued at $599,357.44. This trade represents a 16.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Karen Akinsanya sold 16,723 shares of the company's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total transaction of $419,580.07. Following the completion of the transaction, the insider now directly owns 15,625 shares in the company, valued at approximately $392,031.25. The trade was a 51.70 % decrease in their position. The disclosure for this sale can be found here. 8.60% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Schrödinger
A number of institutional investors have recently added to or reduced their stakes in SDGR. Point72 Hong Kong Ltd bought a new stake in shares of Schrödinger during the 4th quarter worth $27,000. Paradigm Asset Management Co. LLC purchased a new stake in Schrödinger in the fourth quarter worth approximately $50,000. GAMMA Investing LLC grew its position in Schrödinger by 87.5% during the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock valued at $54,000 after acquiring an additional 1,305 shares during the last quarter. KBC Group NV raised its stake in shares of Schrödinger by 73.9% during the fourth quarter. KBC Group NV now owns 4,361 shares of the company's stock worth $84,000 after acquiring an additional 1,853 shares in the last quarter. Finally, Bayesian Capital Management LP bought a new stake in shares of Schrödinger in the 4th quarter worth approximately $199,000. 79.05% of the stock is currently owned by institutional investors.
About Schrödinger
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
See Also
Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
